Author’s Reply to De Ponti et al.: “Pharmacokinetics in Patients with Chronic Liver Disease and Hepatic Safety of Incretin-Based Therapies for the Management of Type 2 Diabetes Mellitus”
Crossref DOI link: https://doi.org/10.1007/s40262-015-0249-3
Published Online: 2015-02-27
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Scheen, André J.
Text and Data Mining valid from 2015-02-27
